JP2004517075A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517075A5
JP2004517075A5 JP2002544437A JP2002544437A JP2004517075A5 JP 2004517075 A5 JP2004517075 A5 JP 2004517075A5 JP 2002544437 A JP2002544437 A JP 2002544437A JP 2002544437 A JP2002544437 A JP 2002544437A JP 2004517075 A5 JP2004517075 A5 JP 2004517075A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002544437A
Other versions
JP2004517075A (ja
JP4348081B2 (ja
Filing date
Publication date
Priority claimed from GBGB0117075.2A external-priority patent/GB0117075D0/en
Application filed filed Critical
Priority claimed from PCT/US2001/044835 external-priority patent/WO2002042303A2/en
Publication of JP2004517075A publication Critical patent/JP2004517075A/ja
Publication of JP2004517075A5 publication Critical patent/JP2004517075A5/ja
Application granted granted Critical
Publication of JP4348081B2 publication Critical patent/JP4348081B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002544437A 2000-10-31 2001-10-31 6,9−二置換2−(トランス−1,4−ジアミノシクロヘキシル)−プリンのアシル及びスルホニル誘導体及び抗増殖剤としてのその使用 Expired - Lifetime JP4348081B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24456700P 2000-10-31 2000-10-31
GBGB0117075.2A GB0117075D0 (en) 2000-10-31 2001-07-13 Acyl and sulfonyl derivatives of 6, 9-distributed 2-(trans-1, 4-diaminocyclohexyl)-purines and their use as antiproliferative agents
PCT/US2001/044835 WO2002042303A2 (en) 2000-10-31 2001-10-31 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents

Publications (3)

Publication Number Publication Date
JP2004517075A JP2004517075A (ja) 2004-06-10
JP2004517075A5 true JP2004517075A5 (ja) 2005-12-22
JP4348081B2 JP4348081B2 (ja) 2009-10-21

Family

ID=26246308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002544437A Expired - Lifetime JP4348081B2 (ja) 2000-10-31 2001-10-31 6,9−二置換2−(トランス−1,4−ジアミノシクロヘキシル)−プリンのアシル及びスルホニル誘導体及び抗増殖剤としてのその使用

Country Status (14)

Country Link
EP (1) EP1377579B1 (ja)
JP (1) JP4348081B2 (ja)
AT (1) ATE426603T1 (ja)
AU (2) AU3938802A (ja)
BR (1) BR0115080A (ja)
CA (1) CA2427338C (ja)
DE (1) DE60138140D1 (ja)
DK (1) DK1377579T3 (ja)
ES (1) ES2324763T3 (ja)
IL (1) IL155590A0 (ja)
MX (1) MXPA03003774A (ja)
NO (1) NO20031939L (ja)
NZ (1) NZ525264A (ja)
WO (1) WO2002042303A2 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563810B2 (en) * 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
FR2851248B1 (fr) * 2003-02-18 2005-04-08 Aventis Pharma Sa Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
CA2525207A1 (en) * 2003-06-12 2004-12-23 Novo Nordisk A/S Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
US8389533B2 (en) * 2008-04-07 2013-03-05 Amgen Inc. Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
US9180127B2 (en) 2009-12-29 2015-11-10 Dana-Farber Cancer Institute, Inc. Type II Raf kinase inhibitors
AU2012340200B2 (en) 2011-11-17 2017-10-12 Dana-Farber Cancer Institute, Inc. Inhibitors of c-Jun-N-Terminal Kinase (JNK)
JP6491202B2 (ja) 2013-10-18 2019-03-27 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド サイクリン依存性キナーゼ7(cdk7)の多環阻害剤
EP3236959A4 (en) 2014-12-23 2018-04-25 Dana Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
CA2978518C (en) * 2015-03-27 2023-11-21 Nathanael S. Gray Inhibitors of cyclin-dependent kinases
CA2996978A1 (en) 2015-09-09 2017-03-16 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
US11384083B2 (en) 2019-02-15 2022-07-12 Incyte Corporation Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
WO2020180959A1 (en) 2019-03-05 2020-09-10 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
AR119765A1 (es) 2019-08-14 2022-01-12 Incyte Corp Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2
MX2022004390A (es) 2019-10-11 2022-08-08 Incyte Corp Aminas biciclicas como inhibidores de la cinasa dependiente de ciclina 2 (cdk2).
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
HUP0100931A3 (en) * 1998-02-26 2002-08-28 Aventis Pharma Inc 6,9-disubstituted 2-[trans-(-aminocyclohexyl)amino]purines and pharmaceutical compositions containing them
FR2793794B1 (fr) * 1999-05-21 2001-07-27 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
WO2001044260A2 (en) * 1999-12-17 2001-06-21 Ariad Pharmaceuticals, Inc. Novel purines
EP1244668B1 (en) * 2000-01-07 2006-04-05 Universitaire Instelling Antwerpen Purine derivatives, process for their preparation and use thereof

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ja)
BE2022C502I2 (ja)
BE2022C547I2 (ja)
BE2017C056I2 (ja)
BE2017C051I2 (ja)
BE2017C050I2 (ja)
BE2011C034I2 (ja)
BE2007C047I2 (ja)
AU2002307149A8 (ja)
JP2002180903A5 (ja)
JP2002123218A5 (ja)
BRPI0209186B1 (ja)
BRPI0204884A2 (ja)
CH1379220H1 (ja)
HU0202920D0 (ja)
BE2017C059I2 (ja)
JP2004517075A5 (ja)
JP2001352249A5 (ja)
BRPI0101486B8 (ja)
JP2002168535A5 (ja)
JP2002233504A5 (ja)
BRPI0210463A2 (ja)
JP2002091087A5 (ja)
JP2002218396A5 (ja)
HU0202201D0 (ja)